Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
MERIT MEDICAL SYSTEMS INC
Report date April 02, 2026 · Filed April 02, 2026
Section 16 reporting ended · disclosed 2026-04-02. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2022 Filed Mar 2, 2022 01:01 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 48,566 | $0.00 Strike: $65.03 | $0.00 |
DisclosureSEC source: 0001415889-22-002081 · form4-03012022_050303.xml · derivative · entry 6 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,566 Underlying: Common Stock · 48,566 shares Expires 2029-02-28 F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 25% commencing 2/28/2023. Read SEC document |
| February 26, 2022 Filed Mar 2, 2022 01:01 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantCommon Stock, No Par Value | 17,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002081 · form4-03012022_050303.xml · nonDerivative · entry 1 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 985,596 F1 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee and Board of Directors that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/26/2020. Read SEC document |
| September 08, 2021 Filed Sep 10, 2021 21:42 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $17.27 | $0.00 |
DisclosureSEC source: 0001415889-21-004349 · form4-09102021_020944.xml · derivative · entry 6 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Became exercisable in equal annual installments of 20% commencing 2/13/2016. F1 · ownership.nature: Represents securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Read SEC document |
| September 08, 2021 Filed Sep 10, 2021 21:42 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Tax withholdingCommon Stock, No Par Value | 2,410 | $72.23 | $174,074.30 |
DisclosureSEC source: 0001415889-21-004349 · form4-09102021_020944.xml · nonDerivative · entry 2 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 3,859 F1 · ownership.nature: Represents securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Read SEC document |
| September 08, 2021 Filed Sep 10, 2021 21:42 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 5,000 | $17.27 | $86,350.00 |
DisclosureSEC source: 0001415889-21-004349 · form4-09102021_020944.xml · nonDerivative · entry 1 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 6,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Represents securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Read SEC document |
| March 19, 2021 Filed Mar 24, 2021 01:38 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 58,083 | $0.00 Strike: $56.25 | $0.00 |
DisclosureSEC source: 0001415889-21-001634 · form4-03232021_060307.xml · derivative · entry 5 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,083 Underlying: Common Stock · 58,083 shares Expires 2028-03-19 F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 25% commencing 3/19/2022. Read SEC document |
| March 12, 2021 Filed Mar 17, 2021 01:37 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 4,947 | $59.60 | $294,841.20 |
DisclosureSEC source: 0001415889-21-001528 · form4-03162021_060306.xml · nonDerivative · entry 1 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 967,916 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.60 to $59.63, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:32 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Tax withholdingCommon Stock, No Par Value | 3,893 | $55.72 | $216,917.96 |
DisclosureSEC source: 0001415889-21-001181 · form4-03022021_030350.xml · nonDerivative · entry 2 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 972,863 Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:32 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantCommon Stock, No Par Value | 8,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-001181 · form4-03022021_030350.xml · nonDerivative · entry 1 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 976,756 F1 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on February 26, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:25 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001415889-20-001320 · form4-05222020_030523.xml · derivative · entry 6 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 10/4/2015. F4 · ownership.nature: Represents derivative securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:25 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 5,000 | $44.00 | $220,000.00 |
DisclosureSEC source: 0001415889-20-001320 · form4-05222020_030523.xml · nonDerivative · entry 2 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 1,269 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.00 to $44.01, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:25 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 5,000 | $12.06 | $60,300.00 |
DisclosureSEC source: 0001415889-20-001320 · form4-05222020_030523.xml · nonDerivative · entry 1 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 6,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2020 Filed Mar 11, 2020 01:32 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 50,000 | $0.00 Strike: $17.27 | $0.00 |
DisclosureSEC source: 0001415889-20-000717 · form4-03102020_060329.xml · derivative · entry 8 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 2/13/2016. Read SEC document |
| March 06, 2020 Filed Mar 11, 2020 01:32 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 50,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001415889-20-000717 · form4-03102020_060329.xml · derivative · entry 7 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2021-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 10/4/2015. Read SEC document |
| March 06, 2020 Filed Mar 11, 2020 01:32 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Tax withholdingCommon Stock, No Par Value | 62,075 | $37.58 | $2,332,778.50 |
DisclosureSEC source: 0001415889-20-000717 · form4-03102020_060329.xml · nonDerivative · entry 3 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: Not disclosed F1 · kind: Stock options were exercised in a swap transaction with the Company. 62,075 shares of common stock were surrendered for payroll taxes and payment of the option price. No shares were sold in the open market. Read SEC document |
| March 06, 2020 Filed Mar 11, 2020 01:32 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 50,000 | $17.27 | $863,500.00 |
DisclosureSEC source: 0001415889-20-000717 · form4-03102020_060329.xml · nonDerivative · entry 2 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,029,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock options were exercised in a swap transaction with the Company. 62,075 shares of common stock were surrendered for payroll taxes and payment of the option price. No shares were sold in the open market. Read SEC document |
| March 06, 2020 Filed Mar 11, 2020 01:32 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 50,000 | $12.06 | $603,000.00 |
DisclosureSEC source: 0001415889-20-000717 · form4-03102020_060329.xml · nonDerivative · entry 1 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 979,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock options were exercised in a swap transaction with the Company. 62,075 shares of common stock were surrendered for payroll taxes and payment of the option price. No shares were sold in the open market. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:29 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantPerformance Stock Units · Derivative | 21,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-027395 · a4.xml · derivative · entry 17 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,215 Underlying: Common Stock · 21,215 shares Expires 2023-03-15 F10 · derivative.exercise_price: Each performance share unit represents the Company's commitment to issue one share of Merit Medical Systems, Inc. common stock, subject to achievement of performance criteria. F11 · shares: On February 26, 2020, the reporting person was awarded a target number of performance share units ("PSUs") pursuant to a Performance Stock Unit Award Agreement by and between the Reporting Person and the Issuer. The actual number of PSUs to be awarded to the Reporting Person will be based upon the Issuer's free cash flow measured against its 2020 financial plan over one, two and three-year periods ending December 31, 2020, 2021 and 2022, respectively, and subject to the Reporting Person's continued employment with the Issuer and the conditions set forth in the Stock Unit Award Agreement. F12 · derivative.exercise_date: If earned by the Reporting Person, the PSUs will be awarded not later than March 15 of the year following the Issuer's achievement of the target level of free cash flow, subject to conditions set forth in the Performance Stock Unit Award Agreement. F12 · derivative.expiration_date: If earned by the Reporting Person, the PSUs will be awarded not later than March 15 of the year following the Issuer's achievement of the target level of free cash flow, subject to conditions set forth in the Performance Stock Unit Award Agreement. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:29 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 100,334 | $0.00 Strike: $37.71 | $0.00 |
DisclosureSEC source: 0001104659-20-027395 · a4.xml · derivative · entry 16 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,334 Underlying: Common Stock · 100,334 shares Expires 2027-02-26 F9 · derivative.exercise_date: Becomes exercisable in equal annual installments of 25% commencing 2/26/2021. Read SEC document |
| September 06, 2019 Filed Sep 9, 2019 23:15 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 11,817 | $30.41 | $359,390.42 |
DisclosureSEC source: 0000856982-19-000123 · wf-form4_156807088822957.xml · nonDerivative · entry 2 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse. Disclosed balance after: 1,269 F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.23 to $30.63, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 06, 2019 Filed Sep 9, 2019 23:15 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 150,000 | $30.72 | $4,607,700.00 |
DisclosureSEC source: 0000856982-19-000123 · wf-form4_156807088822957.xml · nonDerivative · entry 1 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 929,991 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.55 to $31.13, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 23:11 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 40,000 | $36.86 | $1,474,480.00 |
DisclosureSEC source: 0000856982-19-000111 · wf-form4_156599707094808.xml · nonDerivative · entry 4 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,079,991 F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.67 to $37.11, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 23:54 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 159,151 | $0.00 Strike: $55.73 | $0.00 |
DisclosureSEC source: 0000856982-19-000027 · wf-form4_155183008371557.xml · derivative · entry 15 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,151 Underlying: Common Stock · 159,151 shares Expires 2026-03-01 F8 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 3/1/2020. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 23:54 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 10,000 | $0.00 Strike: $55.73 | $0.00 |
DisclosureSEC source: 0000856982-19-000027 · wf-form4_155183008371557.xml · derivative · entry 14 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Please refer to footnote number four. Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2026-03-01 F8 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 3/1/2020. F4 · ownership.nature: Represents derivative securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 20:46 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 120,000 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001179110-18-008156 · edgar.xml · derivative · entry 6 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 120,000 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 8/11/2012. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 20:46 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Tax withholdingCommon Stock, No Par Value | 70,878 | $52.00 | $3,685,656.00 |
DisclosureSEC source: 0001179110-18-008156 · edgar.xml · nonDerivative · entry 5 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,119,991 F2 · kind: Stock options were exercised in a swap transaction with the Company. 70,878 shares of common stock were surrendered for payroll taxes and payment of the option price. No shares were sold in the open market. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 20:46 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 120,000 | $13.75 | $1,650,000.00 |
DisclosureSEC source: 0001179110-18-008156 · edgar.xml · nonDerivative · entry 4 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,190,869 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Stock options were exercised in a swap transaction with the Company. 70,878 shares of common stock were surrendered for payroll taxes and payment of the option price. No shares were sold in the open market. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:23 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 10,000 | $0.00 Strike: $44.80 | $0.00 |
DisclosureSEC source: 0001179110-18-003695 · edgar.xml · derivative · entry 14 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Please refer to Footnote Number five. Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2025-03-02 F8 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 3/2/2019. F5 · ownership.nature: Represents derivative securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:23 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 38,002 | $0.00 Strike: $44.80 | $0.00 |
DisclosureSEC source: 0001179110-18-003695 · edgar.xml · derivative · entry 13 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,002 Underlying: Common Stock · 38,002 shares Expires 2025-03-02 F8 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 3/2/2019. Read SEC document |
| April 14, 2017 Filed Apr 18, 2017 23:17 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 10,000 | $0.00 Strike: $28.20 | $0.00 |
DisclosureSEC source: 0001179110-17-006053 · edgar.xml · derivative · entry 12 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Please refer to footnote number five. Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-04-14 F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 4/14/2018. F5 · ownership.nature: Represents derivative securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Read SEC document |
| April 14, 2017 Filed Apr 18, 2017 23:17 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 200,000 | $0.00 Strike: $28.20 | $0.00 |
DisclosureSEC source: 0001179110-17-006053 · edgar.xml · derivative · entry 11 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2029-04-14 F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 4/14/2018. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 21:01 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.82 | $0.00 |
DisclosureSEC source: 0001179110-16-029673 · edgar.xml · derivative · entry 6 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2016-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 9/26/2010. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 21:01 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Tax withholdingCommon Stock, No Par Value | 17,628 | $24.50 | $431,886.00 |
DisclosureSEC source: 0001179110-16-029673 · edgar.xml · nonDerivative · entry 5 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,070,869 F8 · kind: Stock options were exercised in a swap transaction with the Company. 17,628 shares of common stock were surrendered in payment of the option exercise price and assorted payroll tax liability. No shares were sold in the open market. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 21:01 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionCommon Stock, No Par Value | 25,000 | $13.82 | $345,500.00 |
DisclosureSEC source: 0001179110-16-029673 · edgar.xml · nonDerivative · entry 4 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,088,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · kind: Stock options were exercised in a swap transaction with the Company. 17,628 shares of common stock were surrendered in payment of the option exercise price and assorted payroll tax liability. No shares were sold in the open market. Read SEC document |
| October 04, 2014 Filed May 22, 2020 21:51 UTC Amendment | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001415889-20-001318 · form4a-05222020_020512.xml · derivative · entry 1 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,000 Underlying: Common Stock · Not disclosed shares Expires 2021-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 10/4/2015. F2 · balance_after: On October 7, 2014, the reporting person filed a Form 4 which omitted a grant of non-qualified stock options to his spouse. This Amended Form 4 is being filed to correct that omission. F3 · ownership.nature: Represents derivative securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Read SEC document |
| August 11, 2011 Filed Jun 6, 2018 20:44 UTC Amendment | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 2,500 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001179110-18-008153 · edgar.xml · derivative · entry 20 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Please refer to footnote number ten (10). Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2018-08-11 F9 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 8/11/2012. F10 · ownership.nature: This Amendment is filed to report the granting of stock options to the reporting person's spouse. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Read SEC document |
| August 11, 2011 Filed Jun 6, 2018 20:44 UTC Amendment | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantNon-qualified stock options (right to buy) · Derivative | 120,000 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001179110-18-008153 · edgar.xml · derivative · entry 19 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2018-08-11 F9 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 8/11/2012. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.